X4 Pharmaceuticals Inc (NASDAQ:XFOR)

0.7726
Delayed Data
As of Nov 28
 +0.0026 / +0.34%
Today’s Change
0.65
Today|||52-Week Range
2.58
-22.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.003.5M
 
 
Depreciation And Amortization400.0K300.0K200.0K155.0K
 
 
 
 
 
 
Operating ExpensesGross Income-400.0K-300.0K-200.0K--
 
 
 
 
General Expenses14.4M24.0M35.9M45.7M
 
 
 
 
 
Research And Development12.7M17.8M28.1M31.0M
 
 
 
 
 
Total Operating Expenses14.8M24.3M36.1M45.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.8M-24.3M-36.1M-42.4M
 
 
 
 
 
Extraordinary Credit1.0K1.4M731.0K0.00
 
 
 
 
Extraordinary Charge0.00-35.0K-462.0K-3.5M
 
 
 
 
Interest Expense On Debt472.0K2.5M2.1M1.0M
 
 
 
 
 
Other Expenses-77.0K104.0K-16.0K-85.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.2M-23.0M-33.9M-43.0M
 
 
 
 
 
Preferred Dividend-19.0K-25.0K-44.0K0.00
 
 
 
 
Net Income-13.2M-23.0M-33.9M-43.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS313.6K397.1K57.3K--
 
 
 
 
Shares To Calculate EPS Diluted313.6K397.1K57.3K--
 
 
 
 
 
Earnings Per ShareEPS-$42.22-$57.92-$592.20--
 
 
 
 
EPS Diluted-$42.22-$57.92-$592.26--